Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in BMRN — Biomarin Pharmaceutical Inc

CIK 1423053 MIAMI, FL
Back to BMRN Full portfolio

Position in BMRN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$64,224,185
-$190,694,509 QoQ
Shares Held
1,122,408
-75.1% QoQ
Ownership
0.580%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#32
of 561 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BMRN Over Time

Shares Held

Position Value (USD)

Derivatives in BMRN

reported options exposure · as of Jun 30, 2026
CallValue
$13,189,210
CallShares
230,500
PutValue
$2,866,722
PutShares
50,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,088,670,159 across 436 Biotechnology names. BMRN ranks #23 (1.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ONC
BeOne Medicines Ltd.
 1,425,517 $406,229,578
2 BBIO
BridgeBio Pharma, Inc.
 3,760,028 $280,046,885
3 INSM
INSMED Inc
 2,556,973 $272,624,460
4 MDGL
Madrigal Pharmaceuticals, Inc.
 507,233 $272,358,759
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 510,430 $253,545,893
6 JAZZ
Jazz Pharmaceuticals plc
 1,006,676 $242,578,715
7 MANE
Veradermics, Inc
 1,877,775 $230,853,658
8 ROIV
Roivant Sciences Ltd.
 5,576,261 $197,343,876

All Filings in BMRN

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $64,224,185 1,122,408
2026-06-30 $2,866,722 50,100
2026-06-30 $13,189,210 230,500
2026-03-31 $7,275,912 128,800
2026-03-31 $254,918,694 4,512,634
2026-03-31 $3,186,036 56,400
2025-12-31 $6,091,575 102,500
2025-12-31 $12,420,870 209,000
2025-12-31 $81,103,585 1,364,691
2025-09-30 $21,547,393 397,847
2025-09-30 $11,492,752 212,200
2025-09-30 $5,242,688 96,800
2025-06-30 $5,189,168 94,400
2025-06-30 $10,664,180 194,000
2025-06-30 $18,416,048 335,020
2025-03-31 $13,219,030 187,000
2025-03-31 $112,754,649 1,595,058
2025-03-31 $10,914,536 154,400
2024-12-31 $25,477,802 387,613
2024-12-31 $19,140,576 291,200
2024-12-31 $6,270,642 95,400
2024-09-30 $18,233,226 259,400
2024-09-30 $84,657,064 1,204,397
2024-09-30 $9,615,672 136,800
2024-06-30 $45,927,954 557,852
2024-06-30 $15,321,613 186,100
2024-06-30 $27,679,346 336,200
2024-03-31 $172,545,235 1,975,558
2024-03-31 $5,319,006 60,900
2024-03-31 $10,052,834 115,100
2023-12-31 $9,535,938 98,900
2023-12-31 $9,034,554 93,700
2023-12-31 $34,223,796 354,945
2023-09-30 $5,370,736 60,700
2023-09-30 $28,888,720 326,500
2023-09-30 $12,522,750 141,532
2023-06-30 $7,749,192 89,400
2023-06-30 $41,809,144 482,339
2023-06-30 $18,419,500 212,500
2023-03-31 $12,015,752 123,568
2023-03-31 $12,563,408 129,200
2023-03-31 $18,533,944 190,600
2022-12-31 $9,365,845 90,500
2022-12-31 $13,846,962 133,800
2022-12-31 $13,505,548 130,501
2022-09-30 $84,966,157 1,002,314
2022-09-30 $9,926,567 117,100
2022-09-30 $20,234,599 238,700
2022-06-30 $8,850,516 106,800
2022-06-30 $21,339,025 257,500

Report a Problem

Category
Description
Email (optional, for follow-up)